Indeed, we found more positive correlations between cytokines, especially IL-17A with other cytokines such as TNF-α in psoriasis than those in healthy donors, supporting the notion for treatment with dual inhibition of IL-17A and TNF-α (or other cytokines) in psoriasis patients resistant to single biologics. This evidence concerns the gene TNF and psoriasis.